These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9550762)

  • 1. [Dutch drug registration: greater openness is urgently desired].
    Toenders WG; van Loenhout JW
    Ned Tijdschr Geneeskd; 1997 Oct; 141(43):2051-4. PubMed ID: 9550762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dutch drug registration: more openness highly desired].
    Lekkerkerker JF; Broekmans AW
    Ned Tijdschr Geneeskd; 1998 Jan; 142(2):100. PubMed ID: 9557003
    [No Abstract]   [Full Text] [Related]  

  • 3. [More openness about the registration of drugs in the Netherlands. College for the Review of Medicinal Products].
    Konijnendijk A; Lekkerkerker JF
    Ned Tijdschr Geneeskd; 1998 Jul; 142(28):1621-3. PubMed ID: 9763846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [European registration of medicines: pros and cons for prescriber and patient].
    Offerhaus L
    Ned Tijdschr Geneeskd; 1997 May; 141(21):1028-33. PubMed ID: 9340558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [European registration of drugs; consequences for prescriber and patient].
    Lekkerkerker JF; Broekmans AW
    Ned Tijdschr Geneeskd; 1997 Jul; 141(29):1446. PubMed ID: 9542874
    [No Abstract]   [Full Text] [Related]  

  • 6. Generics: what is the role of registration authorities.
    Versantvoort C; Maliepaard M; Lekkerkerker F
    Neth J Med; 2008 Feb; 66(2):62-6. PubMed ID: 18292608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [European registration of drugs; consequences for prescriber and patient].
    van Grootheest AC
    Ned Tijdschr Geneeskd; 1997 Jun; 141(26):1305-6. PubMed ID: 9380178
    [No Abstract]   [Full Text] [Related]  

  • 8. [European drug policy].
    Sauer F
    Bull Mem Acad R Med Belg; 1993; 148(5-6):207-12; discussion 212-6. PubMed ID: 8142930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical evaluation of efficacy and adverse effects in the (European) registration of drugs: what does it mean for the doctor and patient?].
    Koopmans PP; de Graeff PA; van Zwieten-Boot BJ; Lekkerkerker JF; Broekmans AW
    Ned Tijdschr Geneeskd; 2000 Apr; 144(16):756-61. PubMed ID: 10812445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Registration of veterinary drugs: order or chaos?].
    Sybesma W
    Tijdschr Diergeneeskd; 1993 May; 118(9):308-9. PubMed ID: 8488491
    [No Abstract]   [Full Text] [Related]  

  • 11. [Statement by the Board for Evaluation of Drugs].
    Ned Tijdschr Geneeskd; 1996 Nov; 140(46):2304-5. PubMed ID: 8984389
    [No Abstract]   [Full Text] [Related]  

  • 12. Provision of information on regulatory authorities' websites.
    Vitry A; Lexchin J; Sasich L; Dupin-Spriet T; Reed T; Bertele V; Garattini S; Toop L; Hurley E
    Intern Med J; 2008 Jul; 38(7):559-67. PubMed ID: 18336542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The Veterinary Drug Act and the practice for domestic animals].
    Takkenberg RJ
    Tijdschr Diergeneeskd; 1987 Apr; 112(8):478-80. PubMed ID: 3576583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [European registration of veterinary drugs].
    Reijnders PJ
    Tijdschr Diergeneeskd; 1993 Apr; 118(8):271-4. PubMed ID: 8484182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Orphan drugs: some legal, ethical and economics aspects].
    Pabst JY
    Rev Epidemiol Sante Publique; 2001 Sep; 49(4):387-96. PubMed ID: 11567205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [EUROCAT registration of congenital abnormalities and multiple births; aims, methods and results of the Dutch share of the project 1981-1983].
    Cornel MC; Swagemakers ML; te Meerman GJ; Haayer EJ; ten Kate LP
    Ned Tijdschr Geneeskd; 1986 Jul; 130(27):1233-7. PubMed ID: 3736700
    [No Abstract]   [Full Text] [Related]  

  • 17. [Registration of new medicinal products in Europe].
    Singer E
    Onkologie; 2008; 31 Suppl 2():64-6. PubMed ID: 18487872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Generics: authorization to market and quality guarantees].
    De Muylder JA
    Rev Med Brux; 2000 Sep; 21(4):A276-8. PubMed ID: 11068480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Registration and distribution of veterinary drugs up to and after 1992].
    Frens J
    Tijdschr Diergeneeskd; 1990 Jan; 115(1):22-6. PubMed ID: 2305380
    [No Abstract]   [Full Text] [Related]  

  • 20. [Drugs after 1992; a comparison with yet many unknowns].
    Boer EJ
    Ned Tijdschr Geneeskd; 1990 Sep; 134(38):1863-7. PubMed ID: 2215761
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.